A Study to Evealuate Safety, Reactogenicity, and Immunogenicity of TI-0010 Vaccine in Healthy Adults
Conditions: COVID-19; COVID-19 Immunisation Interventions: Biological: TI-0010; Biological: Placebo Sponsors: National Drug Clinical Trial Institute of the Second Affiliated Hospital of Bengbu Medical College; Therorna Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 15, 2024 Category: Research Source Type: clinical trials
F01 in the Treatment of Relapsed/Refractory Non-hodgkin's Lymphoma
Conditions: Non-Hodgkin ' s Lymphoma Interventions: Drug: After preconditioning with chemotherapy, F01 will be evaluated. Sponsors: Shanghai Simnova Biotechnology Co.,Ltd.; Wuhan Union Hospital, China Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 15, 2024 Category: Research Source Type: clinical trials
Sodium Citrate in Smell Retraining for People With Post-COVID-19 Olfactory Dysfunction
Conditions: Long Haul COVID-19; Post-Acute COVID-19 Syndrome; Anosmia; Olfaction Disorders Interventions: Drug: Sodium Citrate; Drug: Normal Saline; Other: Olfactory Training Kit - " The Olfactory Kit, by AdvancedRx " Sponsors: University of North Carolina, Chapel Hill Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2024 Category: Research Source Type: clinical trials
To Investigate the Effect of 2019 Novel Coronavirus Infection on the Condition of Patients With Hyperthyroidism
Conditions: Hyperthyroidism; COVID-19 Interventions: Other: Thyroid metabolic index Sponsors: Qilu Hospital of Shandong University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2024 Category: Research Source Type: clinical trials
Personalized exposure and experience sampling method feedback versus exposure as usual for obsessive –compulsive disorder: a study protocol for a randomized controlled trial
This study aims to compare personalized exposure with response prevention (ERP) using experience sampling methodology-based feedback to ERP as usual in patients with OCD. Personalized exposure will be provided screen-to-screen in a n ecologically valid (real time and real place) context by means of a smartphone application. This app will also be used to collect both objective and subjective data by means of experience sampling methodology (ESM). This ESM data will be used to identify triggers and protective factors for symptom severity, provide personalized feedback and optimize the effect of ERP. The primary goal of this ...
Source: Trials - January 12, 2024 Category: Research Source Type: clinical trials
Study of Prevalence of the Covid-19 Among the Staff of the Emergency Department
Conditions: COVID-19 Sponsors: University Hospital, Strasbourg, France Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials
Edge AI-deployed DIGItal Twins for PREDICTing Disease Progression and Need for Early Intervention in Infectious and Cardiovascular Diseases Beyond COVID-19 - Investigation of Biomarkers in Dermal Interstitial Fluid
Conditions: Heart Failure Interventions: Device: Use of the PELSA System for dISF extraction Sponsors: Charite University, Berlin, Germany Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials
Delivering COVID-19 vaccine trials at speed: the implementation of a phase IV UK multi-centre randomised controlled trial to determine safety and immunogenicity of COVID-19 vaccines co-administered with seasonal influenza vaccines (ComFluCOV)
ConclusionThe rapid delivery of ComFluCOV was resource intensive. It was made possible in part due to a unique set of circumstances created by the pandemic situation including measures put in place to support urgent public health research and public support for COVID-19 vaccine research. Elements of the trial could be adopted to increase efficiency in ‘non-pandemic’ situations including working with a clinical trials unit to enable immediate mobilisation of a team of experienced researchers, greater sharing of resources between clinical trials units, use of electronic trial systems and virtual meetings.Trial registrati...
Source: Trials - January 11, 2024 Category: Research Source Type: clinical trials
Effectiveness of BNT162b2 Formulations Using State Vaccine Registry and Insurance Claims Data
Conditions: SARS-CoV-2; COVID-19 Vaccines Interventions: Biological: Vaccination Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials
Moxibustion for the Prevention of Hemorrhagic Cystitis After Allo-HSCT
Conditions: Moxibustion; Hematopoietic Stem Cell Transplantation; Hemorrhagic Cystitis; Prevention Interventions: Other: Moxibustion; Other: Symptomatic treatment Sponsors: Wuhan Union Hospital, China Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials
Phase III Clinical Study Evaluating the Efficacy and Safety of WPV01 in Patients With Mild/Moderate COVID-19
Conditions: Mild to Moderate COVID-19 Interventions: Drug: WPV01; Drug: Placebo Sponsors: Westlake Pharmaceuticals (Hangzhou) Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2024 Category: Research Source Type: clinical trials
Impact of COVID-19 on Surgical Outcomes
Conditions: COVID-19, Long Haul; COVID-19 Surgical Outcomes; COVID-19 Post Operative Complications Interventions: Procedure: Major surgery involving general anesthesia Sponsors: Kern Medical Center Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2024 Category: Research Source Type: clinical trials
Cardiac Dysfunction in Critically Ill Covid-19 Patients
Conditions: COVID-19; ARDS, Human; Cardiac Failure; Right Ventricular Dysfunction; Left Ventricular Dysfunction; Pulmonary Hypertension Sponsors: Region Stockholm; Karolinska Institutet Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2024 Category: Research Source Type: clinical trials
Integrated Mindfulness-based Health Qigong Intervention for COVID-19 Survivors and Caregivers
Conditions: COVID-19 Infection Interventions: Other: Mindfulness-based Health Qigong Intervention Sponsors: The Hong Kong Polytechnic University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 8, 2024 Category: Research Source Type: clinical trials
Consequences in ICU of Vaccination Status of Covid-19 Patients
Conditions: SARS CoV 2 Infection Sponsors: Centre Hospitalier R égional Metz-Thionville Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials
